How Enterprise Population & Public Health Board Members Actually Make Decisions

• •polio eradication in next five years as major milestone
• •building vertically integrated supply chains with manufacturer-to-country visibility
• •addressing chronic workforce shortages in rural areasNew
• •leveraging outcomes-based contracts for drug efficacyNew
• •ensuring credibility and scientific rigor in self-care products

+10 more PRO

• •excess labor associated with administrative and revenue cycle rolesNew
• •challenge of convincing people to change diet and exercise
• •glp-1 drugs cost $1,000 or $2,000 a month
• •difficultly in measuring prevention with traditional methods
• •rising healthcare costs for hospitals, doctors, and premiumsNew

+10 more PRO

• •supply chain visibility system implementation across countries
• •polio eradication status within 5 years
• •90% had positive experiences with new health devices
• •returns for shareholders
• •reduction in scheduling, registration, consents, prior auth, rev cycleNew

+10 more PRO

• •multistakeholder coordination loop—identify gaps through visibility, escalate as 'rules by exceptions' for conversation, adjust shipment timing
• •customer-led niche development: listen to customers and what they keep asking for to define focus
• •self-care innovation recipe: broad medical unmet need + big consumer unmet need + right technology + evidence + great product experience
• •bipartisan agreement: seek consensus between republicans and democrats on policy elements
• •shared objective of lives saved—alignment mechanism across organizations with differing operational approaches

+10 more PRO

• •creating a 'gap' and then asking hospitals to transformNew
• •patients getting care they don't need or care that could hurt themNew
• •lack of patient adherence to medication over time
• •systems that overwhelm downstream infrastructure rather than fitting capacity constraints
• •overly conservative and cautious approach to technology

+10 more PRO